Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
Clinical trial NCT06976944 · RECRUITING
Trial details
- NCT number
- NCT06976944
- Sponsor
- Yukinori Ozaki
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2029-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.